Where Chinese Investors Meet Global Investment News and Opportunities

中國投資者探索環球投資新聞及機遇

Zai Lab Pays $15 Million for China Rights to Electric Field Therapy for Brain Cancer

Zai Lab acquired greater China rights to Novocure ‘s Optune, paying $15 million upfront. Optune is a therapy that uses electric fields, called Tumor Treating Fields, that are tuned to specific frequencies to treat cancer. The fields disrupt cell division, inhibiting tumor growth. The treatment is approved to treat brain cancer. In addition to the upfront payment, Zai will also make development, regulatory and commercial milestone payments, plus royalties. Zai will help Novocure by accelerating patient enrollment for new indications.

Source: China Biotoday

Do NOT follow this link or you will be banned from the site!